Publications by Year

Kracalik I, Mowla S, Basavaraju SV, Sapiano MRP. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module – United States, 2013-2018. Transfusion. 2021 May;61(5):1424-1434. doi: 10.1111/trf.16362. Epub 2021 Apr 20. PMID: 33880771.

Mowla SJ, Kracalik IT, Sapiano MRP, O’Hearn L, Andrzejewski C Jr, Basavaraju SV. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med Rev. 2021 Apr;35(2):78-84. doi: 10.1016/j.tmrv.2021.03.003. Epub 2021 Apr 2. PMID: 33934903; PMCID: PMC8175014.

Mowla SJ, Drexler NA, Cherry CC, Annambholta PD, Kracalik IT, Basavaraju SV. Ehrlichiosis and Anaplasmosis among Transfusion and Transplant Recipients in the United States. Emerg Infect Dis. 2021 Nov;27(11):2768-2775. doi: 10.3201/eid2711.211127. PMID: 34670661; PMCID: PMC8544963.

Mowla, S. J., Sapiano, M., Jones, J. M., Berger, J. J., & Basavaraju, S. V. (2021). Supplemental findings of the 2019 National Blood Collection and Utilization Survey. Transfusion, 61 Suppl 2(Suppl 2), S11–S35. https://doi.org/10.1111/trf.16606

Savinkina AA, Haass KA, Sapiano MRP, Henry RA, Berger JJ, Basavaraju SV, Jones JM. Transfusion-associated adverse events and implementation of blood safety measures – findings from the 2017 National Blood Collection and Utilization Survey. Transfusion. 2020 Mar;60 Suppl 2(Suppl 2):S10-S16. doi: 10.1111/trf.15654. PMID: 32134123; PMCID: PMC7908682.

Haass KA, Sapiano MRP, Savinkina A, Kuehnert MJ, Basavaraju SV. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med Rev. 2019 Apr;33(2):84-91. doi: 10.1016/j.tmrv.2019.01.001. Epub 2019 Jan 25. PMID: 30930009; PMCID: PMC6520165.

Jones JM, Gurbaxani BM, Asher A, Sansom S, Annambhotla P, Moorman AC, Kamili S, Brooks JT, Basavaraju SV. Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors. Am J Transplant. 2019 Sep;19(9):2583-2593. doi: 10.1111/ajt.15393. Epub 2019 May 10. PMID: 30980600; PMCID: PMC6946117.

Busch, M. P., Bloch, E. M., & Kleinman, S. (2019). Prevention of transfusion-transmitted infections. Blood, The Journal of the American Society of Hematology, 133(17), 1854-1864.

Centers for Disease Control and Prevention (CDC). Fatal Sepsis Associated with Bacterial Contamination of Platelets – Utah and California, August 2017. MMWR 2018; 67(25):718-722.

Levy JH, Neal MD, Herman JH. Bacterial contamination of platelets for transfusion: strategies for prevention. Crit Care. 2018 Oct 27;22(1):271. doi: 10.1186/s13054-018-2212-9. PMID: 30367640; PMCID: PMC6204059.

Horth, Roberta Z., Jones Jefferson M., Kim, Janice J. Fatal Sepsis Associated with Bacterial Contamination of Platelets — Utah and California, August 2017. MMWR  2018; 67(25);718–722.

Venkat H, Adams L, Sunenshine R, et al. St. Louis encephalitis virus possibly transmitted through blood

transfusion-Arizona, 2015. Transfusion. 2017;57(12):2987-2994.

Sapiano MRP, Savinkina AA, Ellingson KD, et al. Supplemental findings from the National Blood Collection and

Utilization Surveys, 2013 and 2015. Transfusion. 2017;57 Suppl 2:1599-1624.

Ellingson KD, Sapiano MRP, Haass KA, et al. Cost projections for implementation of safety interventions to prevent transfusion-transmitted Zika virus infection in the United States. Transfusion. 2017;57 Suppl 2(Suppl 2):1625-1633.

Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion. 2017;57 Suppl 2(Suppl 2):1588-1598.

Chevalier MS, Biggerstaff BJ, Basavaraju SV, et al. Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016. Emerg Infect Dis. 2017;23(5):790-795.

Centers for Disease Control and Prevention (CDC). Zika Virus —10 Public Health Achievements in 2016 and Future Priorities. MMWR 2017; 65:1482-1488.

Chung KW, Basavaraju SV, Mu Y, et al. Declining blood collection and utilization in the United States. Transfusion. 2016;56(9):2184-92.

Willson S, Miller K, Seem D, Kuehnert MJ. Cognitive evaluation of the AABB Uniform Donor History Questionnaire. Transfusion. 2016;56(6 Pt 2):1662-1667.

Centers for Disease Control and Prevention (CDC). Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure – United States, September 2016. MMWR 2016; 65.

Centers for Disease Control and Prevention (CDC). Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure – United States, 2016. MMWR 2016; 65(12):215-322.

Centers for Disease Control and Prevention (CDC). Screening of Blood Donations for Zika Virus Infection- Puerto Rico, April 3-June 11, 2016. MMWR 2016; 65.

Centers for Disease Control and Prevention (CDC). Progress Toward Strengthening National Blood Transfusion Services — 14 Countries, 2011–2014. MMWR 2016; 65:115-119.

Centers for Disease Control and Prevention (CDC). Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection- Puerto Rico, 2016. MMWR 2016; 65(14):375-378.

Centers for Disease Control and Prevention (CDC). Update: Ongoing Zika Virus Transmission – Puerto Rico, November 1, 2015- July 7 2016. MMWR 2016; 65(30):774-779.

Centers for Disease Control and Prevention (CDC). Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure – United States, 2016. MMWR 2016; 65(12);315-322.

Basavaraju SV, Kuehnert MJ. Custodes invicem custodiunt (the watchmen can watch each other). Transfusion. 2015;55(9):2293-4.

Moorman AC, Stramer SL, Schaefer MK, et al. Incident hepatitis among repeat blood donors: A sentinel event signaling possible health care-associated infection and need for reporting to public health authorities. Transfusion. 2015;55(10):2531-3.

Chung KW, Harvey A, Basavaraju SV, Kuehnert MJ. How is national recipient hemovigilance conducted in the United States? Transfusion. 2015;55(4):703-707.

Harvey AR, Basavaraju SV, Chung KW, Kuehnert MJ. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion. 2015;55(4):709-718.

Dollard SC, Roback JD, Gunthel C, et al. Measurements of human herpesvirus 8 viral load in blood before and after leukoreduction filtration. Transfusion. 2013;53(10):2164-2167.

Menon M, Graves L, McCombs K, et al. Listeria monocytogenes in donated platelets: a potential transfusion-transmitted pathogen intercepted through screening. Transfusion. 2013;53(9):1974-1978.

Centers for Disease Control and Prevention (CDC). Transmission of Hepatitis C Virus Through Transplanted Organs and Tissue – Kentucky and Massachusetts, 2011. MMWR 2011; 60(50);1697-1700.

Centers for Disease Control and Prevention (CDC). HIV Transmission through Transfusion — Missouri and Colorado, 2008. MMWR 2010; 59(41);1335-1339.

Centers for Disease Control and Prevention (CDC). West Nile Virus Transmission via Organ Transplantation and Blood Transfusion — Louisiana, 2008. MMWR 2009; 58(45);1263-1267.

Cannon MJ, Operskalski EA, Mosley JM, Radford K, Dollard SC. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. Journal of Infectious Diseases 2009; 199(11):1592-8.

Lessa F, Leparc GF, Benson K, Sanderson R, VanBeneden CA, Shewmaker PL, Jensen B, Arduino MJ, Kuehnert MJ. Fatal group C streptococcal infection due to transfusion of a bacterially contaminated pooled platelet unit despite routine bacterial culture screening. Transfusion 2008; 48(10); 2177–2183

Centers for Disease Control and Prevention (CDC). Anaplasma phagocytophilum transmitted through blood transfusion-Minnesota, 2007. MMWR 2008. 57(42);1145-1148.

Centers for Disease Control and Prevention (CDC). West Nile Virus transmission through blood transfusion — South Dakota, 2006. MMWR 2007; 56(04);76-79.

Centers for Disease Control and Prevention (CDC). Blood Donor Screening for Chagas Disease–United States, 2006–2007. MMWR 2007. 56(07);141-143.

Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, Norris PJ; National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II). Influenza viremia and the potential for blood-borne transmission. Transfusion 2007; 47(6):1080-8.

Rao PL, Strausbaugh LJ, Liedtke LA, Srinivasan A, Kuehnert MJ, Infectious Diseases Society of America Emerging Infections Network. Bacterial infections associated with blood transfusion: experience and perspective of infectious diseases consultants. Transfusion. 2007;47(7):1206-11.

Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM. Transmission of Human Herpesvirus 8 by blood transfusion. New England Journal of Medicine 2006; 355:1331-1338.

Heneine W, Kuehnert MJ. Preserving blood safety against emerging retroviruses. Transfusion 2006; 46(8):1276-8.

Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ, Brecher ME; Task Force. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey. Transfusion 2006; 46(4):636-41.

Centers for Disease Control and Prevention (CDC). Update: West Nile Virus Screening of Blood Donations and Transfusion-Associated Transmission — United States, 2003. MMWR 2004; 53(13); 281-284.

Gowland P, Fontana S, Niederhauser C, Taleghani BM. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus. Transfusion 2004; 44(11):1555-61.

Centers for Disease Control and Prevention (CDC). Probable Transfusion-Transmitted Malaria — Houston, Texas, 2003. MMWR 2003; 52(44);1075-1076.

Centers for Disease Control and Prevention (CDC). Blood Safety Monitoring Among Persons With Bleeding Disorders—United States, May 1998–June 2002. MMWR 2003;51:1152-1154.

Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999 [PDF – 97 KB]. New England Journal of Medicine 2001; 344(26).

Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee, Jarvis WR. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41(12): 1493-1499.

Roth VR, Kuehnert MJ, Haley NR, Gregory KR, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Elder KV, Jarvis WR. Evaluation of a reporting system for bacterial contamination of blood components in the United States. Transfusion 2001; 41(12): 1486-1492.

Dodd R. The risk of transfusion-transmitted infection. New England Journal of Medicine 1992; 327(6): 419.

For current guideline, visit the Transplant Safety website.

Clarification of human immunodeficiency virus screening practices for organ donors [PDF – 1 page], 61 Fed Reg 1996;61:56548.

Rogers MF, Simonds RJ, Lawton KE, Moseley RR, Jones WK. Guidelines for preventing transmission of human Immunodeficiency virus through transplantation of human tissue and organs. MMWR Recomm Rep 1994;43(RR-8):1-17.

Public Health Service Inter-Agency Guidelines for Screening Donors of Blood, Plasma, Organs, Tissues and Semen for Evidence of Hepatitis B and Hepatitis C MMWR April 19, 1991; 40(RR-4);1-17.

Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR Morb Mortal Wkly Rep 1985;34(20):294.